Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study to Assess the Burden of Drug-resistant Partial Epilepsy in Italy

NCT01332539 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01332539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01332539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study to Assess the Burden of Drug-resistant Partial Epilepsy in Italy
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
May 31, 2011
Completion date
November 30, 2012
Enrollment
240 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, partial